Blog
Topic
Product
The Multitron incubator shaker remains uniquely popular since its launch in 1991. The original concept was to offer maximum shake flask capacity whilst occupying minimum space within the laboratory. A number of other new features were launched alongside the Multitron, and since have become firm favourites with users. Some of the best loved capabilities of the Multitron are listed below.
At INFORS HT, our mission is to provide superior products and services that improve bioprocess workflows and enable our customers to focus on their core mission. We believe in the power of partnerships that drive innovation, foster growth and deliver exceptional results. Hence we are thrilled to share the success story of FairJourney Biologics, an innovative Contract Research Organization specialized in Antibody Discovery and Production.
Your lab depends on healthy growing cells, and these cells depend on the continuous operation of your incubation shakers. The last thing you want in your lab is unscheduled downtime. Servicing your incubation shaker is important to maintain accuracy, prevent contamination, optimize productivity and extend lifespan, especially if you use it in a laboratory for research or production settings where precision, reliability and consistency are crucial.
In recent years, mRNA (messenger RNA) technology has emerged as a groundbreaking tool in the field of medicine, revolutionizing the way we approach disease prevention and treatment. This cutting-edge technology holds tremendous promise for combating a wide range of diseases, including infectious diseases, cancer and genetic disorders.
As the workhorses of life, proteins fulfil a variety of functions in our bodies. If their functionality is limited or missing, diseases can arise. Therefore, proteins and their production are a central key to research. Whether protein expression is to be controlled for experimental, biotechnological, or medical applications, the use of cells is often mandatory. Many researchers repeatedly face the same challenge of producing complex target protein fast and cheap. Transient transfection of recombinant plasmids (rpDNA) in mammalian cells is a popular method for this purpose. In the following article, we look at the success story of research assistant Damian von Blarer, who must produce specific regions of the famous SARS-CoV-2 spike protein for efficiency studies of a rapid test – for this he needs plasmids, and we show which questions you need to answer to produce and amplify them easily yourself.
The idea of using our own cells to produce antibodies essential for survival no longer belongs to science fiction. Although it has been the focus of researchers for decades, the direct use of messenger RNA encoding antibodies has received recent market approval due to the urgency of the COVID-19 pandemic. As such, this platform technology is revolutionizing the way we think about biopharmaceutical production and has great potential for further applications. In the following article, you will learn about the key aspects of the application, production and use of mRNA, the software of life.
The continuing bioprocess automation brings new challenges. Industry 4.0 pushes us to strengthen the cohesion between people, processes and technologies. How can we develop systems and functions that provide an enhanced user experience and enable a substantial, organic relationship between software and people? Tacking on new functionality to existing solutions is one option, but the opportunity to rebuild using proven new approaches is too important to miss. Here we take you behind the scenes of our software development.
The scale–up from bench-top bioreactors to larger, pilot systems can seem daunting. The list of user requirements specifications is much longer, and the manufacturer will provide a peculiar drawing called a P&ID. Reading these is second nature to a Bioprocess Engineer. For someone without such a background, this may be a strange concept. Nevertheless, with a bioreactor in the centre of your process, it is vital to link bioprocess technology and mechanical engineering in a schematic representation. This article shows you how to interpret your P&ID and to understand the functionalities of your bioreactor and its capabilities.
Freeing a port on a small bioreactor can increase its capability. We give you some practical examples how to allow a small bioreactor to outperform its original design limitations.
The Multitron incubator shaker remains uniquely popular since its launch in 1991. The original concept was to offer maximum shake flask capacity whilst occupying minimum space within the laboratory. A number of other new features were launched alongside the Multitron, and since have become firm favourites with users. Some of the best loved capabilities of the Multitron are listed below.
At INFORS HT, our mission is to provide superior products and services that improve bioprocess workflows and enable our customers to focus on their core mission. We believe in the power of partnerships that drive innovation, foster growth and deliver exceptional results. Hence we are thrilled to share the success story of FairJourney Biologics, an innovative Contract Research Organization specialized in Antibody Discovery and Production.
Your lab depends on healthy growing cells, and these cells depend on the continuous operation of your incubation shakers. The last thing you want in your lab is unscheduled downtime. Servicing your incubation shaker is important to maintain accuracy, prevent contamination, optimize productivity and extend lifespan, especially if you use it in a laboratory for research or production settings where precision, reliability and consistency are crucial.
In recent years, mRNA (messenger RNA) technology has emerged as a groundbreaking tool in the field of medicine, revolutionizing the way we approach disease prevention and treatment. This cutting-edge technology holds tremendous promise for combating a wide range of diseases, including infectious diseases, cancer and genetic disorders.
As the workhorses of life, proteins fulfil a variety of functions in our bodies. If their functionality is limited or missing, diseases can arise. Therefore, proteins and their production are a central key to research. Whether protein expression is to be controlled for experimental, biotechnological, or medical applications, the use of cells is often mandatory. Many researchers repeatedly face the same challenge of producing complex target protein fast and cheap. Transient transfection of recombinant plasmids (rpDNA) in mammalian cells is a popular method for this purpose. In the following article, we look at the success story of research assistant Damian von Blarer, who must produce specific regions of the famous SARS-CoV-2 spike protein for efficiency studies of a rapid test – for this he needs plasmids, and we show which questions you need to answer to produce and amplify them easily yourself.
The idea of using our own cells to produce antibodies essential for survival no longer belongs to science fiction. Although it has been the focus of researchers for decades, the direct use of messenger RNA encoding antibodies has received recent market approval due to the urgency of the COVID-19 pandemic. As such, this platform technology is revolutionizing the way we think about biopharmaceutical production and has great potential for further applications. In the following article, you will learn about the key aspects of the application, production and use of mRNA, the software of life.
The continuing bioprocess automation brings new challenges. Industry 4.0 pushes us to strengthen the cohesion between people, processes and technologies. How can we develop systems and functions that provide an enhanced user experience and enable a substantial, organic relationship between software and people? Tacking on new functionality to existing solutions is one option, but the opportunity to rebuild using proven new approaches is too important to miss. Here we take you behind the scenes of our software development.
The scale–up from bench-top bioreactors to larger, pilot systems can seem daunting. The list of user requirements specifications is much longer, and the manufacturer will provide a peculiar drawing called a P&ID. Reading these is second nature to a Bioprocess Engineer. For someone without such a background, this may be a strange concept. Nevertheless, with a bioreactor in the centre of your process, it is vital to link bioprocess technology and mechanical engineering in a schematic representation. This article shows you how to interpret your P&ID and to understand the functionalities of your bioreactor and its capabilities.
Freeing a port on a small bioreactor can increase its capability. We give you some practical examples how to allow a small bioreactor to outperform its original design limitations.